Reducing overtreatment in gynecologic oncology: The case for less in endometrial and ovarian cancer

Sarah M. Temkin*, Edward James Tanner, Summer B. Dewdney, Lori M. Minasian

*Corresponding author for this work

Research output: Contribution to journalShort surveypeer-review

4 Scopus citations

Abstract

A growing awareness of the harms of overtreatment in cancer care has reached physicians, patients, health policy makers, and medical researchers. Overtreatment exposes patients to the risk of adverse events from procedures or medications that were not necessary. This review examines common practices in gynecologic malignancies that are unlikely to produce direct benefit to patients with these malignancies, but are likely to produce harms. Specifically, we will explore the utility of lymphadenectomy and adjuvant radiation for women with early-stage endometrial cancer; and screening for recurrence and continuous chemotherapy for advanced-stage ovarian cancer patients.

Original languageEnglish (US)
Article number118
JournalFrontiers in Oncology
Volume6
Issue numberMAY
DOIs
StatePublished - 2016

Keywords

  • Cancer care delivery
  • Endometrial cancer
  • Gynecologic cancer
  • Ovarian cancer
  • Overtreatment

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint

Dive into the research topics of 'Reducing overtreatment in gynecologic oncology: The case for less in endometrial and ovarian cancer'. Together they form a unique fingerprint.

Cite this